Php239 - The Introduction and Implications of the Cost-Containment Measure ‘The Sluice’ for Expensive Innovative Drugs in the Netherlands

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1133
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The First Experiences With Reassessments and Appraisals of Conditionally Approved Expensive and Orphan Drugs in the Netherlands (2006-2013)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Physician Use of Services for the Hospitalized Patient: A Review, With Implications for Cost Containment

The Milbank Memorial Fund Quarterly. Health and Society
1981English

The Complexities and Perplexities of Cost Containment.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1989English

Medicaid Cost Containment and Access to Prescription Drugs

Health Affairs
MedicineHealth Policy
2005English

Impact of a Cost Containment Program on the Use of Volatile Anesthetics and Neuromuscular Blocking Drugs

Journal of Clinical Anesthesia
AnesthesiologyPain Medicine
1994English

The Reimbursement of Expensive Drugs in Hospitals in Western European Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

The Promise of Health Care Cost Containment

Health Affairs
MedicineHealth Policy
2007English

Cost Containment and New Priorities in the European Community

Milbank Quarterly
Health PolicyPublic HealthOccupational HealthEnvironmental
1992English

Geochemical Mapping in the Kingdom of the Netherlands: Introduction

Geologie en Mijnbouw/Netherlands Journal of Geosciences
Geology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy